Nature, Published online: 14 September 2022; doi:10.1038/d41586-022-02892-5
When combined, two drugs alter the activity of a protein complex called target of rapamycin complex 1 such that it is inhibited in the brain but not the body, enabling the treatment of brain tumours in mice without systemic toxicity.
More News
Seed-stashing chickadees overturn ideas about location memory
Stereospecific alkenylidene homologation of organoboronates by SNV reaction – Nature
Publisher Correction: A molecular map of the immune response region from the major histocompatibility complex of the mouse – Nature